Sun Pharma is here to support you
during the COVID-19 pandemic
Menu
Menu

Ilumya HCP Just another WordPress site

  • Results
  • Safety
  • Dosing
  • MOA
  • Support/Resources
  • Connect with Us >
  • COVID-19 Information
  • Prescribing Information
  • Medication Guide
  • Patient Site >

Site map

HOME

Results

Residual Disease

PASI Improvement

Study Design

SAFETY

Chart View

Table View

Dosing

MOA

SUPPORT/RESOURCES

ILUMYA SUPPORT®

Downloadable Resources

CONNECT WITH US

  • SUN Dermatology
  • Sun Pharma
  • Privacy Policy
  • Terms of Use
  • Site Map
  • Contact Us
  • Connect with Us >
  • COVID-19 Information
  • Prescribing Information
  • Medication Guide
  • Patient Site >
SUN_Derm_Logo Created with Sketch.

Sun Pharmaceutical Industries Ltd test description

The ILUMYA trademarks are the property of Sun Pharma Global FZE. © 2021 SUN Dermatology, a division of Sun Pharmaceutical Industries, Inc. All rights reserved. PM-US-ILY-1382 03/2021

Are you a healthcare professional?

The information presented in this website is intended for US healthcare professionals only.

Select the appropriate option:

NO YES

You are now leaving ILUMYAPro.com

The link you clicked will take you to a third-party site,
which is solely responsible for its content.
Sun Pharma does not control or influence this site.

CANCEL CONTINUE
Close

You are now leaving ILUMYAPro.com

The link you clicked will take you to a third-party site, which is solely responsible for its content.
Sun Pharma does not control or influence this site.

CANCEL CONTINUE